Delhi, India
I operate at the intersection of clinical strategy, translational science, and oncology drug development decision-making. Currently, I lead translational strategy and external partnerships at Genestac Therapeutics, focusing on advancing oncology programs through patient-derived tumor organoid platforms that enable more predictive drug response insights. In parallel, I am the Founder & Managing Director of Novitalis Clinical Expansion Intelligence, an independent sponsor-side intelligence platform supporting biotech and pharmaceutical companies in evaluating India clinical trial expansion decisions with structured, data-driven clarity. With over 18 years of global clinical development experience, I have supported complex clinical programs across multiple geographies, working closely with sponsors to address challenges related to enrollment dynamics, site performance variability, and capital exposure. My work today focuses on: • Enabling translational decision-making through organoid-based drug response models • Supporting early-phase oncology programs with data-driven insights • Advising sponsors on India expansion strategy and feasibility risks • Building collaborative partnerships across biotech, pharma, and research organizations I work with organizations seeking to bring greater predictability, efficiency, and clarity to oncology drug development.
Lead the strategic development and external positioning of Genestac’s clinical-translational oncology ecosystem by integrating clinical research insight, translational science strategy, and strategic partnership development. Support the alignment between: translational platforms oncology clinical development biomarker-driven programs organoid-based response models strategic collaborations scientific-commercial expansion initiatives Act as a strategic interface between: clinical research translational medicine oncology development biotech partnerships ecosystem expansion Clinical Research & Development Strategy Support clinical-translational alignment for oncology-focused programs Contribute clinical development perspective to translational platform positioning Support feasibility thinking for future translational and clinical applications Align scientific capabilities with emerging oncology trial and biomarker needs Provide strategic input around global oncology development trends
Focused on executive-level clinical execution intelligence for early-phase oncology biotech sponsors, protecting enrollment momentum, capital alignment, and critical data-readout timelines. Core focus areas: • Early activation enrollment diagnostics • Cohort velocity and variance monitoring • Burn rate optimization through accrual alignment • Structured operational recovery strategy
• Prepare Project Plan as per the project timelines, budget and deliverables. • Complete the assigned project in a Qualitative, cost-effective, and time-bound manner. • Guide the software team in developing new platforms and features • Gather and provide feedback on features and enhancements that may be needed on an ongoing basis to the Development team. • Coordinate with multiple stakeholders to activate sites • Lead and coordinate with a team to ensure seamless implementation of our platforms at the sites • Ensuring compliance with the Protocol, SOPs, ICH-GCP, and other applicable regulatory requirements. • Responsible for Study updates & coordination with other trial-related service providers as per study requirements. • Helping mentor and train new employees • Help the sales team with customer lead generation. • Track timelines, milestones, and budget requirements for assigned projects. • Assist with User Acceptance Testing during product development and release. • Coordinate planning and conduct of clinical trial projects in liaison with other interdepartmental team members. • Provide protocol specific training to the team, including therapeutic expertise, study procedures, and SOPs. • Prepare reports and updates for sponsors. • Ensure effective communication between stakeholders and all project team members.